<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03004573</url>
  </required_header>
  <id_info>
    <org_study_id>69 HCL15_0760</org_study_id>
    <nct_id>NCT03004573</nct_id>
  </id_info>
  <brief_title>Role of Deep Brain Stimulation on Social Cognition in Parkinsonian Patients</brief_title>
  <official_title>Functioning of the Mirror Neurons System in Parkinson's Disease and Its Impact on the Social Cognition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Parkinson's disease (PD) is usually responsible of cognitive and behavioral non-motor signs
      with a major impact on the quality of life. Social cognition is a complex system relying on
      emotion recognition (neurons mirror system, NMS), the theory of mind (with its two parts:
      emotional and cognitive), but also on the social and cultural environment and the personal
      history. The first step in this model is represented by the NMS, which seems to be altered in
      PD patients for both positive and negative emotions as shown in our preliminary study. The
      investigator purpose is to investigate the role of the treatment (levodopa and deep brain
      stimulation) on the functioning of the NMS.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 14, 2017</start_date>
  <completion_date type="Anticipated">December 14, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 14, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>variation of the emotional recognition score (point lights test) before deep brain surgery</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>variation of the emotional recognition score (point lights test) after deep brain surgery</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>PDQ39 score (Parkinson's Disease Questionnaire)</measure>
    <time_frame>1 year</time_frame>
    <description>Quality of Life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MATTIS (dementia rating scale) score</measure>
    <time_frame>1 year</time_frame>
    <description>Global cognition. The Clinical Dementia Rating or CDR is a numeric scale used to quantify the severity of symptoms of dementia</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Deep brain stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neuropsychological detailed tests with focus on social cognition</intervention_name>
    <description>MATTIS, MOCA, BREF, Light points test, PDQ39</description>
    <arm_group_label>Deep brain stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parkinson's disease with motor fluctuations and dyskinesias receiving deep-brain
             stimulation

          -  Social insurance

        Exclusion Criteria:

          -  No affiliation to the social insurance

          -  Patients under guardianship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Teodor Danaila, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Teodor Danaila, MD</last_name>
    <phone>0427857741</phone>
    <phone_ext>+33</phone_ext>
    <email>teodor.danaila@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hélène MERLE</last_name>
    <email>helene.merle@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de Neurologie C Hôpital &quot; Pierre Wertheimer &quot;</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teodor DANAILA, MD</last_name>
      <phone>0427857741</phone>
      <phone_ext>+33</phone_ext>
      <email>teodor.danaila@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Hélène MERLE</last_name>
      <email>helene.merle@chu-lyon.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Teodor DANAILA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jing XIE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre KROLAK-SALMON, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chloé LAURENCIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuel Broussolle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane THOBOIS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2016</study_first_submitted>
  <study_first_submitted_qc>December 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2016</study_first_posted>
  <last_update_submitted>March 30, 2018</last_update_submitted>
  <last_update_submitted_qc>March 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Parkinson Disease</keyword>
  <keyword>emotional recognition</keyword>
  <keyword>Deep Brain Stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

